CA Stock MarketDetailed Quotes
VXL Vaxil Bio Ltd
- 0.010
- 0.0000.00%
15min DelayTrading May 22 16:00 ET
1.37MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.010Pre Close0.00Turnover0.03552wk High0.00%Turnover Ratio136.98MShares0.00552wk Low--EPS TTM1.26MFloat Cap1.960Historical HighLossP/E (Static)125.69MShs Float0.005Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM1.67P/B1Lot Size--Div YieldTTM
Vaxil Bio Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 87.80%-20K | 23.57%-561K | 62.30%-69K | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K |
| Net income from continuing operations | 53.60%-58K | 56.51%-254K | 115.03%26K | 79.86%-28K | 13.01%-127K | 0.79%-125K | 40.77%-584K | 38.21%-173K | 41.84%-139K | 30.14%-146K |
| Depreciation and amortization | ---- | --0 | --0 | --0 | ---- | ---- | -92.00%2K | --0 | --0 | --0 |
| Remuneration paid in stock | -25.00%3K | 17.65%20K | 20.00%6K | -20.00%8K | 100.00%2K | 300.00%4K | -75.71%17K | --5K | -37.50%10K | -93.75%1K |
| Change In working capital | 181.40%35K | -93.49%-327K | -573.33%-101K | -7.41%-29K | -631.03%-154K | 72.44%-43K | 12.44%-169K | -111.54%-15K | 65.38%-27K | 125.22%29K |
| -Change in receivables | 127.27%25K | -163.64%-7K | -20.00%4K | 45.45%16K | -137.50%-38K | 0.00%11K | -86.59%11K | 25.00%5K | 650.00%11K | -150.00%-16K |
| -Change in payables and accrued expense | 118.52%10K | -77.78%-320K | -425.00%-105K | -18.42%-45K | -357.78%-116K | 67.66%-54K | 34.55%-180K | -115.87%-20K | 50.00%-38K | 130.61%45K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 87.80%-20K | 23.57%-561K | 62.30%-69K | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -37.88%938K | -32.62%1.51M | -40.12%1.01M | -42.30%1.06M | -31.53%1.34M | -32.62%1.51M | 48.41%2.24M | -27.56%1.69M | -29.99%1.84M | -33.60%1.96M |
| Current changes in cash | 87.80%-20K | 23.57%-561K | 62.30%-69K | 68.59%-49K | -140.52%-279K | 41.22%-164K | -201.38%-734K | -86.73%-183K | 47.83%-156K | 62.34%-116K |
| Effect of exchange rate changes | 150.00%2K | -466.67%-11K | -125.00%-2K | -100.00%-6K | --1K | -100.00%-4K | -57.14%3K | -38.46%8K | 66.67%-3K | --0 |
| End cash Position | -31.45%920K | -37.88%938K | -37.88%938K | -40.12%1.01M | -42.30%1.06M | -31.53%1.34M | -32.62%1.51M | -32.62%1.51M | -27.56%1.69M | -29.99%1.84M |
| Free cash from | 87.80%-20K | 23.57%-561K | 62.30%-69K | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg